U.S. Global Health Legislation Tracker
This tracker provides a listing of global health-related legislation introduced in the current Congress.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This tracker provides a listing of global health-related legislation introduced in the current Congress.
This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX's organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.
Countries are seeking to create a new 'pandemic agreement' at WHO to strengthen pandemic prevention, preparedness, and response. This brief explains what the pandemic agreement is, where the U.S. stands on issues included in the agreement, and potential outcomes of the ongoing negotiations. It also evaluates several criticisms of the agreement and the evidence for each.
This fact sheet summarizes the major statutory requirements and policies pertaining to U.S. global family planning/reproductive health (FP/RH) efforts over time and identifies those currently in effect.
While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country. In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.
This fact sheet examines Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in lower income countries, and explores the role the U.S. government plays in supporting the partnership.
On March 1, 2011, the Kaiser Family Foundation hosted a town hall-style forum with Lois Quam, the newly appointed Executive Director of the Global Health Initiative (GHI), to listen to global health community perspectives on the progress of the initiative to date and discuss what the future of the
This issue brief examines existing treaties and other global health agreements to assess whether they have been utilized for the COVID-19 pandemic response and whether they contain pandemic preparedness and response components in their mandates. The COVID-19 pandemic challenged and revealed gaps in global health governance systems, prompting stakeholders to reevaluate existing frameworks and discuss new agreements aimed at addressing future pandemics. To help inform these discussions, we evaluate existing global health agreements to assess their role in pandemic preparedness and response efforts, including the COVID-19 pandemic.
This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.
Public Believes Much Aid Is Lost To Corruption MENLO PARK, Calif. – Two-thirds of Americans say that the U.S. is spending too little or about the right amount on global health with one in five saying spending is too high, according to a new Kaiser Family Foundation survey on the public's views of global health issues.
© 2026 KFF